Avacincaptad Pegol
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 72 publications
Geographic atrophy: From slowing lesions to preserving vision.
Journal: Current opinion in ophthalmology
Published: May 09, 2026
Real-world Safety Profile of Avacincaptad Pegol in the Management of Geographic Atrophy.
Journal: Ophthalmic surgery, lasers & imaging retina
Published: March 27, 2026
Off-label intravitreal eculizumab for geographic atrophy: report of the first two cases.
Journal: International journal of retina and vitreous
Published: December 12, 2025
Novel drug development for geographic atrophy.
Journal: Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)
Published: December 08, 2025
Integrative Landscape of Dry AMD Pathogenesis, Models, and Emerging Therapeutic Strategies.
Journal: International journal of molecular sciences
Published: November 21, 2025
Efficacy of Intravitreal Pegcetacoplan vs Avacincaptad Pegol in Patients With Geographic Atrophy.
Journal: Journal of vitreoretinal diseases
Published: October 20, 2025
Small RNA or oligonucleotide drugs and challenges in evaluating drug-drug interactions.
Journal: Frontiers in pharmacology
Published: October 07, 2025
Real-World Experience of Geographic Atrophy Treatment With Avacincaptad Pegol.
Journal: Journal of vitreoretinal diseases
Published: September 08, 2025
Aptamers as therapeutic targets: prospects and progress in the treatment of cancers.
Journal: Nucleosides, nucleotides & nucleic acids
Published: June 06, 2025
Safety and tolerability of avacincaptad pegol in combination with ranibizumab in treatment-naïve patients with neovascular age-related macular degeneration: results from a phase 1 and phase 2a study.
Journal: BMJ open ophthalmology
Published: June 05, 2025
Last Updated: 06/30/2026